Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension Latest News

Recently, Natco Pharma has received U.S. Food and Drug Administration final approval for Bosentan tablets for oral suspension, its generic version of Actelion Pharmaceuticals US Inc.’s pulmonary arterial hypertension(PAH) drug Tracleer.

About Pulmonary Arterial Hypertension

• It is a specific type of pulmonary hypertension that is caused when the tiny arteries in your lung become thickened and narrowed.
• This blocks the blood flow through your lungs which raises the blood pressure in the lungs and causes your heart to work harder to pump your blood through those narrowed arteries.

Causes of Pulmonary Arterial Hypertension

• The exact cause of PAH is unknown but it is believed that PAH occurs when there is injury to the cells that line the blood vessels of the lung, which over time results in this blood vessel disease.
• It can also develop in association with other medical conditions including congenital heart disease, liver disease, HIV and connective tissue diseases — such as scleroderma and lupus.
• PAH can even be associated with past or present drug use, such as the use of methamphetamine or certain diet pills.

Symptoms of Pulmonary Arterial Hypertension: Blue fingers or lips, Chest pain, Dizziness or fainting, Fatigue, Shortness of breath that gets worse over time etc.

Treatment for Pulmonary Arterial Hypertension: While there are treatment options for PAH, there is no known cure.

Pulmonary Arterial Hypertension FAQs

Q1: What is the main cause of pulmonary arterial hypertension?

Ans: Unknown cause, called idiopathic pulmonary arterial hypertension.

Q2: What is the new treatment for hypertension?

Ans: The FDA approved a new treatment for uncontrolled high blood pressure. The once-daily oral medication, called Tryvio (aprocitentan).

Q3: Which food increases BP?

Ans: Salty Foods which incorporate foods high in sodium, such as pickles, olives, salted nuts, and canned soups,

‹ ›

Source: TH